Sinocelltech Group Limited — Investor Relations & Filings
Sinocelltech Group Limited focuses on the research, development, and commercialization of innovative biologics, including monoclonal antibodies, recombinant proteins, and vaccine candidates. The company's product pipeline addresses therapeutic areas such as oncology, autoimmune disorders, hematology, and infectious diseases. Key offerings include recombinant human coagulation factor VIII for hemophilia A and a range of biosimilars. Sinocelltech leverages an integrated technology platform encompassing early-stage discovery through to large-scale industrial production. This infrastructure supports the development of high-quality biological medicines aimed at addressing unmet medical needs through advanced protein engineering and cell line development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 神州细胞关于参加十五五·科创惠民——科创板企业成果转化与民生赋能之2025年度制药行业集体业绩说明会暨召开2026年第一季度业绩说明会的公告 | 2026-04-29 | Chinese | |
| 神州细胞2025年年度股东会会议资料 | 2026-04-29 | Chinese | |
| 神州细胞关于新增募投项目实施主体后签订募集资金专户存储四方监管协议的公告 | 2026-04-29 | Chinese | |
| 神州细胞2026年第一季度报告 | 2026-04-29 | Chinese | |
| 神州细胞董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-22 | Chinese | |
| 神州细胞2025年度独立董事述职报告（苏志国） | 2026-04-22 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39240617 | 神州细胞关于参加十五五·科创惠民——科创板企业成果转化与民生赋能之2025年度制药行业集体业绩说明会暨召开2026年第一季度业绩说明会的公告 | 2026-04-29 | Chinese | ||
| 39240606 | 神州细胞2025年年度股东会会议资料 | 2026-04-29 | Chinese | ||
| 39240603 | 神州细胞关于新增募投项目实施主体后签订募集资金专户存储四方监管协议的公告 | 2026-04-29 | Chinese | ||
| 39240594 | 神州细胞2026年第一季度报告 | 2026-04-29 | Chinese | ||
| 39240586 | 神州细胞董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-22 | Chinese | ||
| 39240583 | 神州细胞2025年度独立董事述职报告（苏志国） | 2026-04-22 | Chinese | ||
| 39240580 | 神州细胞第三届董事会第七次会议决议公告 | 2026-04-22 | Chinese | ||
| 39240577 | 神州细胞关于召开2025年年度股东会的通知 | 2026-04-22 | Chinese | ||
| 39240575 | 中信证券股份有限公司关于北京神州细胞生物技术集团股份公司2026年度日常关联交易预计的核查意见 | 2026-04-22 | Chinese | ||
| 39240559 | 关于北京神州细胞生物技术集团股份公司2025年度营业收入扣除情况的专项说明 | 2026-04-22 | Chinese | ||
| 39240556 | 神州细胞关于2025年度利润分配方案的公告 | 2026-04-22 | Chinese | ||
| 39240551 | 董事和高级管理人员薪酬管理办法 | 2026-04-22 | Chinese | ||
| 39240546 | 神州细胞2025年度独立董事述职报告（何为） | 2026-04-22 | Chinese | ||
| 39240542 | 神州细胞2025年度内部控制审计报告 | 2026-04-22 | Chinese | ||
| 39240459 | 神州细胞2025年度独立董事述职报告（张学） | 2026-04-22 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sinocelltech Group Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58462/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58462 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58462 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58462 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58462}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sinocelltech Group Limited (id: 58462)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.